Skip to main content
SpringerLink
Log in

Genetics and Family Screening for Noncompaction Cardiomyopathy

  • Chapter
  • First Online:
Book cover Noncompaction Cardiomyopathy

  • 395 Accesses

Abstract

In at least half the patients diagnosed with noncompaction cardiomyopathy (NCCM) genetics plays an important role. In familial NCCM, like in other inherited cardiomyopathies, timely identification and treatment of relatives at risk is important. This chapter focusses on the process of identifying a genetic cause, predicting risk for relatives, informing index cases and relatives on subsequent recommendations for family screening.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bleyl SB, Mumford BR, Thompson V, Carey JC, Pysher TJ, Chin TK, et al. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth Syndrome. Am J Hum Genet. 1997;61(4):868–72.

    Article  CAS  Google Scholar 

  2. Hoedemaekers YM, Caliskan K, Majoor-Krakauer D, van de Laar I, Michels M, Witsenburg M, et al. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J. 2007;28(22):2732–7.

    Article  CAS  Google Scholar 

  3. Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, et al. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation. 2008;117(22):2893–901.

    Article  CAS  Google Scholar 

  4. van Waning JI, Caliskan K, Hoedemaekers YM, van Spaendonck-Zwarts KY, Baas AF, Boekholdt SM, et al. Genetics, clinical features, and long-term outcome of noncompaction cardiomyopathy. J Am Coll Cardiol. 2018;71(7):711–22.

    Article  Google Scholar 

  5. Sedaghat-Hamedani F, Haas J, Zhu F, Geier C, Kayvanpour E, Liss M, et al. Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy. Eur Heart J. 2017;38(46):3449–60.

    Article  CAS  Google Scholar 

  6. Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2010;31(22):2715–26.

    Article  Google Scholar 

  7. Gati S, Rajani R, Carr-White GS, Chambers JB. Adult left ventricular noncompaction: reappraisal of current diagnostic imaging modalities. JACC Cardiovasc Imaging. 2014;7(12):1266–75.

    Article  Google Scholar 

  8. Hoedemaekers YM, Caliskan K, Michels M, Frohn-Mulder I, van der Smagt JJ, Phefferkorn JE, et al. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet. 2010;3(3):232–9.

    Article  Google Scholar 

  9. Kawel-Boehm N, McClelland RL, Zemrak F, Captur G, Hundley WG, Liu CY, et al. Hypertrabeculated left ventricular myocardium in relationship to myocardial function and fibrosis: the multi-ethnic study of atherosclerosis. Radiology. 2017;284:667.

    Article  Google Scholar 

  10. Luijkx T, Cramer MJ, Zaidi A, Rienks R, Senden PJ, Sharma S, et al. Ethnic differences in ventricular hypertrabeculation on cardiac MRI in elite football players. Neth Heart J. 2012;20(10):389–95.

    Article  CAS  Google Scholar 

  11. Gati S, Chandra N, Bennett RL, Reed M, Kervio G, Panoulas VF, et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart. 2013;99(6):401–8.

    Article  CAS  Google Scholar 

  12. Vatta M, Mohapatra B, Jimenez S, Sanchez X, Faulkner G, Perles Z, et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol. 2003;42(11):2014–27.

    Article  CAS  Google Scholar 

  13. Michels M, Soliman OI, Phefferkorn J, Hoedemaekers YM, Kofflard MJ, Dooijes D, et al. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers. Eur Heart J. 2009;30(21):2593–8.

    Article  CAS  Google Scholar 

  14. Budde BS, Binner P, Waldmuller S, Hohne W, Blankenfeldt W, Hassfeld S, et al. Noncompaction of the ventricular myocardium is associated with a de novo mutation in the beta-myosin heavy chain gene. PLoS One. 2007;2(12):e1362.

    Article  Google Scholar 

  15. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92(4):785–9.

    Article  CAS  Google Scholar 

  16. Wessels MW, Herkert JC, Frohn-Mulder IM, Dalinghaus M, van den Wijngaard A, de Krijger RR, et al. Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects. Eur J Hum Genet. 2015;23(7):922–8.

    Article  CAS  Google Scholar 

  17. Finsterer J, Stollberger C. Spontaneous left ventricular hypertrabeculation in dystrophin duplication based Becker’s muscular dystrophy. Herz. 2001;26(7):477–81.

    Article  CAS  Google Scholar 

  18. Amiya E, Morita H, Hatano M, Nitta D, Hosoya Y, Maki H, et al. Fukutin gene mutations that cause left ventricular noncompaction. Int J Cardiol. 2016;222:727–9.

    Article  Google Scholar 

  19. Alston CL, Ceccatelli Berti C, Blakely EL, Olahova M, He L, McMahon CJ, et al. A recessive homozygous p.Asp92Gly SDHD mutation causes prenatal cardiomyopathy and a severe mitochondrial complex II deficiency. Hum Genet. 2015;134(8):869–79.

    Article  CAS  Google Scholar 

  20. Finsterer J, Bittner R, Bodingbauer M, Eichberger H, Stollberger C, Blazek G. Complex mitochondriopathy associated with 4 mtDNA transitions. Eur Neurol. 2000;44(1):37–41.

    Article  CAS  Google Scholar 

  21. Tang S, Batra A, Zhang Y, Ebenroth ES, Huang TS. Left ventricular noncompaction is associated with mutations in the mitochondrial genome. Mitochondrion. 2010;10(4):350–7.

    Article  CAS  Google Scholar 

  22. Ojala T, Polinati P, Manninen T, Hiippala A, Rajantie J, Karikoski R, et al. New mutation of mitochondrial DNAJC19 causing dilated and noncompaction cardiomyopathy, anemia, ataxia, and male genital anomalies. Pediatr Res. 2012;72(4):432–7.

    Article  CAS  Google Scholar 

  23. Cremer K, Ludecke HJ, Ruhr F, Wieczorek D. Left-ventricular non-compaction (LVNC): a clinical feature more often observed in terminal deletion 1p36 than previously expected. Eur J Med Genet. 2008;51(6):685–8.

    Article  Google Scholar 

  24. Pauli RM, Scheib-Wixted S, Cripe L, Izumo S, Sekhon GS. Ventricular noncompaction and distal chromosome 5q deletion. Am J Med Genet. 1999;85(4):419–23.

    Article  CAS  Google Scholar 

  25. McMahon CJ, Chang AC, Pignatelli RH, Miller-Hance WC, Eble BK, Towbin JA, et al. Left ventricular noncompaction cardiomyopathy in association with trisomy 13. Pediatr Cardiol. 2005;26(4):477–9.

    Article  CAS  Google Scholar 

  26. Brouwers C, Caliskan K, Bos S, Van Lennep JE, Sijbrands EJ, Kop WJ, et al. Health status and psychological distress in patients with non-compaction cardiomyopathy: the role of burden related to symptoms and genetic vulnerability. Int J Behav Med. 2015;22(6):717–25.

    Article  Google Scholar 

  27. Morales A, Cowan J, Dagua J, Hershberger RE. Family history: an essential tool for cardiovascular genetic medicine. Congest Heart Fail. 2008;14(1):37–45.

    Article  Google Scholar 

  28. van Waning JI, Caliskan K, Michels M, Schinkel AFL, Hirsch A, Dalinghaus M, Hoedemaekers YM, Wessels MW, IJpma AS, Hofstra RMW, van Slegtenhorst MA, Majoor-Krakauer D. Cardiac phenotypes, genetics, and risks in familial noncompaction cardiomyopathy. J Am Coll Cardiol. 2019;73(13):1601–11. https://doi.org/10.1016/j.jacc.2018.12.085.

    Article  PubMed  Google Scholar 

  29. Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat. 2008;29(11):1282–91.

    Article  CAS  Google Scholar 

  30. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.

    Article  Google Scholar 

  31. Abbasi Y, Jabbari J, Jabbari R, Yang RQ, Risgaard B, Kober L, et al. The pathogenicity of genetic variants previously associated with left ventricular non-compaction. Mol Genet Genomic Med. 2016;4(2):135–42.

    Article  CAS  Google Scholar 

  32. Walsh R, Buchan R, Wilk A, John S, Felkin LE, Thomson KL, et al. Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes. Eur Heart J. 2017;38(46):3461–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Walsh R, Thomson KL, Ware JS, Funke BH, Woodley J, McGuire KJ, et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2017;19(2):192–203.

    Article  Google Scholar 

  34. Stahli BE, Gebhard C, Biaggi P, Klaassen S, Valsangiacomo Buechel E, Attenhofer Jost CH, et al. Left ventricular non-compaction: prevalence in congenital heart disease. Int J Cardiol. 2013;167(6):2477–81.

    Article  Google Scholar 

  35. Vermeer AM, van Engelen K, Postma AV, Baars MJ, Christiaans I, De Haij S, et al. Ebstein anomaly associated with left ventricular noncompaction: an autosomal dominant condition that can be caused by mutations in MYH7. Am J Med Genet C Semin Med Genet. 2013;163C(3):178–84.

    Article  Google Scholar 

  36. Ichida F, Tsubata S, Bowles KR, Haneda N, Uese K, Miyawaki T, et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation. 2001;103(9):1256–63.

    Article  CAS  Google Scholar 

  37. van der Roest WP, Pennings JM, Bakker M, van den Berg MP, van Tintelen JP. Family letters are an effective way to inform relatives about inherited cardiac disease. Am J Med Genet A. 2009;149A(3):357–63.

    Article  Google Scholar 

  38. Authors/Task Force Members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733–79.

    Article  Google Scholar 

  39. Fanos JH. Developmental tasks of childhood and adolescence: implications for genetic testing. Am J Med Genet. 1997;71(1):22–8.

    Article  CAS  Google Scholar 

  40. Bratt EL, Ostman-Smith I, Axelsson A, Berntsson L. Quality of life in asymptomatic children and adolescents before and after diagnosis of hypertrophic cardiomyopathy through family screening. J Clin Nurs. 2013;22(1–2):211–21.

    Article  Google Scholar 

  41. Pieper PG, Walker F. Pregnancy in women with hypertrophic cardiomyopathy. Neth Heart J. 2013;21(1):14–8.

    Article  CAS  Google Scholar 

  42. European Society of Gynecology, Association for European Paediatric Cardiology, German Society for Gender Medicine, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147–97.

    Article  Google Scholar 

  43. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet. 1986;1(8493):1287–93.

    Article  CAS  Google Scholar 

  44. Pedra SR, Smallhorn JF, Ryan G, Chitayat D, Taylor GP, Khan R, et al. Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome. Circulation. 2002;106(5):585–91.

    Article  Google Scholar 

  45. Hoedemaekers YM, Cohen-Overbeek TE, Frohn-Mulder IM, Dooijes D, Majoor-Krakauer DF. Prenatal ultrasound diagnosis of MYH7 non-compaction cardiomyopathy. Ultrasound Obstet Gynecol. 2013;41(3):336–9.

    Article  CAS  Google Scholar 

  46. Stollberger C, Wegner C, Benatar A, Chin TK, Dangel J, Majoor-Krakauer D, et al. Postnatal outcome of fetal left ventricular hypertrabeculation/noncompaction. Pediatr Cardiol. 2016;37(5):919–24.

    Article  Google Scholar 

  47. Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM. Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A. 2009;149A(4):602–12.

    Article  Google Scholar 

  48. Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM. Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients’ perspective. Am J Med Genet A. 2009;149A(7):1444–51.

    Article  Google Scholar 

  49. Wynn J, Holland DT, Duong J, Ahimaz P, Chung WK. Examining the psychosocial impact of genetic testing for cardiomyopathies. J Genet Couns. 2018;27:927.

    Article  Google Scholar 

  50. Hoedemaekers E, Jaspers JP, Van Tintelen JP. The influence of coping styles and perceived control on emotional distress in persons at risk for a hereditary heart disease. Am J Med Genet A. 2007;143A(17):1997–2005.

    Article  Google Scholar 

  51. Vernon SW, Gritz ER, Peterson SK, Amos CI, Baile WF, Perz CA, et al. Design and methodology of a study of psychosocial aspects of genetic testing for hereditary colorectal cancer. Ann N Y Acad Sci. 1997;833:190–4.

    Article  CAS  Google Scholar 

  52. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104(21):2517–24.

    Article  CAS  Google Scholar 

  53. Thaman R, Gimeno JR, Murphy RT, Kubo T, Sachdev B, Mogensen J, et al. Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy. Heart. 2005;91(7):920–5.

    Article  CAS  Google Scholar 

  54. Charron P, Dubourg O, Desnos M, Bouhour JB, Isnard R, Hagege A, et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J. 1998;19(9):1377–82.

    Article  CAS  Google Scholar 

  55. Gandjbakhch E, Gackowski A, Tezenas du Montcel S, Isnard R, Hamroun A, Richard P, et al. Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler imaging. Eur Heart J. 2010;31(13):1599–607.

    Article  Google Scholar 

  56. Jensen MK, Havndrup O, Christiansen M, Andersen PS, Diness B, Axelsson A, et al. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing. Circulation. 2013;127(1):48–54.

    Article  Google Scholar 

  57. Gray B, Ingles J, Semsarian C. Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy. Int J Cardiol. 2011;152(2):258–9.

    Article  Google Scholar 

  58. Milano A, Vermeer AM, Lodder EM, Barc J, Verkerk AO, Postma AV, et al. HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy. J Am Coll Cardiol. 2014;64(8):745–56.

    Article  CAS  Google Scholar 

  59. Campbell MJ, Czosek RJ, Hinton RB, Miller EM. Exon 3 deletion of ryanodine receptor causes left ventricular noncompaction, worsening catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest. Am J Med Genet A. 2015;167A(9):2197–200.

    Article  Google Scholar 

  60. Shan L, Makita N, Xing Y, Watanabe S, Futatani T, Ye F, et al. SCN5A variants in Japanese patients with left ventricular noncompaction and arrhythmia. Mol Genet Metab. 2008;93(4):468–74.

    Article  CAS  Google Scholar 

Download references

Acknowledgement

J.I. van Waning is supported by a grant from the Jaap Schouten Foundation.

Author information

Authors and Affiliations

  1. Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands

    Jaap I. van Waning & Danielle Majoor-Krakauer

Authors
  1. Jaap I. van Waning
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Danielle Majoor-Krakauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaap I. van Waning .

Editor information

Editors and Affiliations

  1. Erasmus MC University Medical Center, Department of Cardiology, Rotterdam, The Netherlands

    Kadir Caliskan

  2. Erasmus MC University Medical Center, The Thoraxcenter, Rotterdam, The Netherlands

    Osama I. Soliman

  3. Erasmus MC University Medical Center, Department of Cardiology, Rotterdam, The Netherlands

    Folkert J. ten Cate

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

van Waning, J.I., Majoor-Krakauer, D. (2019). Genetics and Family Screening for Noncompaction Cardiomyopathy. In: Caliskan, K., Soliman, O., ten Cate, F. (eds) Noncompaction Cardiomyopathy. Springer, Cham. https://doi.org/10.1007/978-3-030-17720-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17720-1_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17719-5

  • Online ISBN: 978-3-030-17720-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation